Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
 
 
Bluesky
Twitter
Facebook
Telegram
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • FigsFigs
  • TabsTabs
  • DataData
  • RefsRefs
  • CitedCited
CrossRef
(4)
  • Mohammed M. Al-Mahadeen, Areej M. Jaber, Belal O. Al-Najjar, Monther A. Khanfar, Mustafa M. El-Abadelah (2025)
    Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity. Current Organic Synthesis 22: 410. CrossRef DOI: 10.2174/0115701794335274240910111137
  • Mohammed M Al-Mahadeen, Areej M Jaber, Raed A Al-Qawasmeh, Mutasem O Taha (2024)
    Synthesis, evaluation, and docking study of adamantyl-1,3,4-oxadiazol hybrid compounds as CaMKIIδ kinase inhibitor. Journal of Chemical Research 48: . CrossRef DOI: 10.1177/17475198241262467
  • Areej M. Jaber, Mohammed M. Al-Mahadeen, Belal O. Al-Najjar, Raed A. Al-Qawasmeh (2025)
    Synthesis, molecular docking, and anti-inflammatory evaluation of novel 4-(benzo[d][1,3]dioxol-5-yloxy)-N,N-2-yn-1-amine derivatives as potent cysteinyl leukotriene receptor (CysLT2) antagonists. Pharmacia 72: 1. CrossRef DOI: 10.3897/pharmacia.72.e143171
  • Preeti Kumari, Rakhi Mishra, Rupa Mazumder, Avijit Mazumder (2025)
    Acyl Urea Compounds Therapeutics and its Inhibition for Cancers in Women: A Review. Anti-Cancer Agents in Medicinal Chemistry 25: 86. CrossRef DOI: 10.2174/0118715206330232240913100744
    • Subscribe to email alerts for current Article's categories
    Powered by